Supporting the decision to perform molecular profiling for cancer patients based on routinely collected data through the use of machine learning

Background Personalized medicine offers targeted therapy options for cancer treatment. However, the decision whether to include a patient into next-generation sequencing (NGS) testing is not standardized. This may result in some patients receiving unnecessary testing while others who could benefit f...

Ausführliche Beschreibung